Company: LNAI
Filing Date: 2025-10-15
Form Type: DEF 14A
Source: 0001731122-25-001378
Chunk: 66

Company: Lunai Bioworks Inc.
Filing Date: 2025-10-15
Form: DEF 14A
Chunk 66
---
 financial
officer will be included in a Current Report on Form 8-K within four business days following the date of the amendment or waiver, unless
website posting or the issuance of a press release of such amendments or waivers is then permitted by the rules of the Nasdaq Stock Market.

<div align='center'>OTHER MATTERS</div>

The persons designated to vote
shares covered by our proxies intend to exercise their judgment in voting such shares on other matters that may properly come before the
Annual Meeting or any adjournment, continuation or postponements thereof. Our Board knows of no other business which will be presented
at the annual meeting. If any other business is properly brought before the annual meeting, proxies will be voted in accordance with the
judgment of the persons named therein.

<div align='center'>FUTURE STOCKHOLDER PROPOSALS</div>

To have a proposal intended to
be presented at our 2025 annual meeting of stockholders be considered for inclusion in the proxy statement and form of proxy relating
to that meeting, a stockholder must deliver written notice of such proposal in writing to the Corporate Secretary at our corporate headquarters
no later than a reasonable period of time before we begin to print and send our proxy materials for our 2025 annual meeting. Such proposal
must also comply with the requirements as to form and substance established by the SEC for such a proposal to be included in the proxy
statement. We reserve the right to reject, rule out of order or take other appropriate action with respect to any proposal that does not
comply with these and other applicable requirements.

<div align='center'>38

ANNEX A

AMENDMENT TO THE STOCK INCENTIVE PLAN

A-1

FIRST AMENDMENT

TO THE

RENOVARO BIOSCIENCES INC.

2023 EQUITY INCENTIVE PLAN</div>

This First Amendment (the “Amendment”)
to the Renovaro BioSciences Inc. 2023 Equity Incentive Plan (“Plan”) is adopted by the. Board of Directors (the “Board”)
of Lunai Bioworks Inc. (the “Company”) on October 12, 2025, subject to approval by the Company’s stockholders
at the Company’s October 31, 2025 Annual Meeting. Capitalized terms used but not otherwise defined in this Amendment have the meanings
given in the Plan.

<div align='center'>Recitals</div>

| C. | Section 5.2 of the Plan provides